Heart Failure Forum-4
|
08:00-10:00 206 |
|---|
| 主持 Moderators | 杨杰孚 Jiefu YANG, 周京敏 Jingmin ZHOU, 黄进宇 Jinyu HUANG, 许洁伟 Jiewei XU, 张瑶 Yao ZHANG, 应淑琴 Shuqin YING | ||
|
08:00-08:20 |
HFpEF（射血分数保留性心衰）治疗的最新进展 State-of-the-Art Lecture in theTreatment of HFpEF |
Carolyn LAM | |
|
08:20-08:40 |
终末期心衰的姑息治疗 Palliative Care for End-Stage Heart Failure |
李凌 Ling LI | |
|
08:40-09:00 |
血糖管理与心衰治疗策略 Blood Glucose Management and Heart Failure Treatment Strategy |
杜贝贝 Beibei DU | |
|
09:00-09:20 |
心衰中心质控考核方案与质控标准&浙江省质控报告 Quality Control Assessment Plan and Standards for Heart Failure Centers & Zhejiang Provincial Quality Control Report |
项美香 Meixiang XIANG | |
|
09:20-09:40 |
从国内外最新指南看心衰高钾血症管理 Management of Heart Failure-Associated Hyperkalemia from the Latest Domestic and International Guidelines |
董蔚 Wei DONG | |
|
09:40-10:00 |
心肌病合并心衰的猝死预防进展 Progress in Sudden Cardiac Death Prevention in Cardiomyopathy Complicated with Heart Failure |
姜萌 Meng JIANG | |
Heart Failure Forum-5
|
10:00-12:00 206 |
|---|
| 主持 Moderators | 王利宏 Lihong WANG, 许轶洲 Yizhou XU, 杨伊萍 Yiping YANG, 刘艳梅 Yanmei LIU | ||
|
10:00-10:20 |
2025ESC-Hotline VICTOR研究解读： sGC刺激剂在HFrEF患者全程管理中的突破性价值 Interpretation of the 2025 ESC-Hotline VICTOR Study: Breakthrough Value of sGC Stimulants in the Whole-Course Management of HFrEF Patients |
周京敏 Jingmin ZHOU | |
|
10:20-10:40 |
正性肌力药物在终末期心衰中的应用 Application of Inotropic Drugs in End-Stage Heart Failure |
张瑶 Yao ZHANG | |
|
10:40-11:00 |
心力衰竭容量管理评估技术进展与意义 Progress and Significance of Volume Management Assessment Technology in Heart Failure |
盛莉 Li SHENG | |
|
11:00-11:20 |
从指南变迁看心衰治疗策略新趋势 New Trends in Heart Failure Treatment Strategies from the Perspective of Guideline Changes |
王留义 Liuyi WANG | |
|
11:20-11:40 |
一例肿瘤药物相关心力衰竭的诊疗实践 Diagnostic and Therapeutic Practice of a Case of Tumor Drug-Related Heart Failure |
李兴红 Xinghong LI | |
|
11:40-12:00 |
讨论 Discussion |
||